Table 2. Serum prostate-specific antigen (PSA) test rates by year in the six age groups.
| Year | Category | Total | Age group | ||||
|---|---|---|---|---|---|---|---|
| 40s | 50s | 60s | 70s | Over 80s | |||
| 2006 | Men with PSA test | 246,911 (2.549) | 22,309 (0.520) | 59,939 (2.218) | 85,115 (4.956) | 61,817 (8.011) | 17,731 (8.786) |
| Population (≥40 y) | 9,686,975 | 4,293,362 | 2,702,636 | 1,717,421 | 771,738 | 201,818 | |
| 2007 | Men with PSA test | 312,888 (3.129) | 32,032 (0.739) | 76,476 (2.682) | 105,637 (5.970) | 76,376 (9.179) | 22,367 (10.497) |
| Population (≥40 y) | 9,999,912 | 4,333,766 | 2,851,682 | 1,769,337 | 832,057 | 213,070 | |
| 2008 | Men with PSA test | 479,046 (4.634) | 49,002 (1.119) | 120,265 (4.006) | 159,922 (8.705) | 116,491 (13.033) | 33,366 (14.706) |
| Population (≥40 y) | 10,337,914 | 4,377,870 | 3,002,131 | 1,837,226 | 893,794 | 226,893 | |
| 2009 | Men with PSA test | 571,643 (5.345) | 57,776 (1.306) | 146,424 (4.619) | 187,875 (9.916) | 138,931 (14.453) | 40,637 (16.675) |
| Population (≥40 y) | 10,694,580 | 4,424,693 | 3,170,224 | 1,894,727 | 961,242 | 243,694 | |
| 2010 | Men with PSA test | 631,417 (5.720) | 60,815 (1.372) | 165,455 (4.910) | 202,810 (10.417) | 156,966 (15.270) | 45,371 (17.358) |
| Population (≥40 y) | 11,039,633 | 4,434,091 | 3,369,420 | 1,946,828 | 1,027,907 | 261,387 | |
| 2011 | Men with PSA test | 700,040 (6.148) | 63,949 (1.442) | 177,734 (4.948) | 221,419 (11.161) | 182,857 (16.676) | 54,081 (19.404) |
| Population (≥40 y) | 11,386,232 | 4,435,055 | 3,592,137 | 1,983,827 | 1,096,507 | 278,706 | |
| 2012 | Men with PSA test | 755,372 (6.443) | 67,523 (1.522) | 190,584 (5.046) | 237,082 (11.705) | 199,180 (16.833) | 61,003 (20.301) |
| Population (≥40 y) | 11,723,878 | 4,437,927 | 3,776,653 | 2,025,529 | 1,183,270 | 300,499 | |
| 2013 | Men with PSA test | 801,241 (6.653) | 67,949 (1.526) | 194,925 (4.986) | 254,260 (12.138) | 215,448 (17.118) | 68,659 (20.972) |
| Population (≥40 y) | 12,042,751 | 4,452,694 | 3,909,234 | 2,094,829 | 1,258,609 | 327,385 | |
| 2014 | Men with PSA test | 831,495 (6.730) | 70,133 (1.567) | 195,618 (4.865) | 267,307 (12.182) | 222,746 (17.063) | 75,691 (21.037) |
| Population (≥40 y) | 12,354,915 | 4,474,484 | 4,020,937 | 2,194,268 | 1,305,432 | 359,794 | |
| 2015 | Men with PSA test | 863,782 (6.836) | 69,845 (1.566) | 195,801 (4.779) | 277,502 (11.846) | 236,259 (17.660) | 84,375 (21.176) |
| Population (≥40 y) | 12,635,426 | 4,459,325 | 4,097,255 | 2,342,576 | 1,337,821 | 398,449 | |
| 2016 | Men with PSA test | 937,548 (7.276) | 73,053 (1.653) | 203,853 (4.906) | 302,065 (12.069) | 263,233 (19.220) | 95,344 (21.677) |
| Population (≥40 y) | 12,886,340 | 4,418,589 | 4,155,589 | 2,502,779 | 1,369,560 | 439,823 | |
Values are presented as number (%) or number only.